News
Enter your email address to get Core One Labs News Alerts.
News
Enter your email address to get Core One Labs News Alerts.
Company News
Core One in Talks with Multiple Companies to Supply Psilocybin
May 05, 2023
Vancouver, British Columbia, Canada – May 5, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN:...
Read more
Company News
Core One Labs’ GMP Drug Takes Further Steps Toward Commercialization: Initiating Development of Psychedelic Prodrugs with Long-established Compounding Pharmacy
May 01, 2023
Vancouver, British Columbia, Canada – May 1, 2023 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN:...
Read more
Company News
Core One’s Awakened Completes Successful Synthetic Production of Psilocin in its GMP Certified Manufacturing Facility
April 21, 2023
Vancouver, British Columbia, Canada – April 21, 2023 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more
Company News
Core One Labs Applauds Study Linking Psychedelic Treatment to Substantial Reduction in Alcohol Misuse & PTSD Symptoms in US Special Operations Forces Veterans
April 04, 2023
Vancouver, British Columbia, Canada – April 4, 2023 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more
Company News
Core One Labs’ Akome Signs Contract with University of Barcelona: Initiating Animal Model Studies on Psychedelics Drug Development to Combat a Variety of Neurological Diseases
January 24, 2023
Vancouver, British Columbia, Canada – January 24, 2023 – Core One Labs Inc. (CSE: COOL), (OTCQB: CLABF), (Frankfurt: LD6, WKN: A3CSSU)...
Read more
Company News
Core One Labs’ Acquires GMP Drug Inc.: Positioning Itself as a Full Cycle Psychedelics Supply Chain Solution for Clinicians, Researchers and other Drug Developers
January 13, 2023
Vancouver, British Columbia, Canada – January 13, 2023 – Core One Labs Inc. (CSE: COOL), (OTCQB: CLABF), (Frankfurt: LD6, WKN: A3CSSU)...
Read more